Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment

INTRODUCTION: Patients with rheumatoid arthritis (RA) have an increased risk of infection and this risk appears to be higher with anti-TNF (tumor necrosis factor) agents. We pooled data from the cumulative abatacept RA clinical development program, both double-blind and open-label periods, to estima...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Teresa A, Askling, Johan, Lacaille, Diane, Franklin, Jarrod, Wolfe, Frederick, Covucci, Allison, Suissa, Samy, Hochberg, Marc C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888222/
https://www.ncbi.nlm.nih.gov/pubmed/20398273
http://dx.doi.org/10.1186/ar2984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888222/
https://www.ncbi.nlm.nih.gov/pubmed/20398273
http://dx.doi.org/10.1186/ar2984

Ejemplares similares